ArticleInternal medicine (Tokyo, Japan)2026

Recurrent IgA1-λ-Type PGNMID Achieving Remission with Conventional Immunosuppressive Therapy.

Kazuki Chida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.